About EOCI

EOCI has a demonstrated track record of over 13 years in the CME industry. Our reputation is a result of business integrity and professional agility, as well as resourcefulness and creativity.

In addition to the 25 to 30 CME programs we develop annually, EOCI produces other high-calibre specialist-focused annual congresses in Mont-Tremblant, and Montreal:

Arrhythmia Update Plus 2019

February 6 to February 9, 2019

Conference Educational Objectives

Following this program participants will be able to:

  • Examine additional outcomes from the COMPASS trial including subgroup and cost-effectiveness analyses
  • Analyze the evidence and expert opinion on arrhythmias and heart failure
  • Examine recent findings from stroke prevention trials including ESUS, POINT, and studies on PFO closure
  • Discuss contemporary strategies for the management of syncope
  • Share best practices on the delivery of care in heart failure
  • Discuss practical approaches for mitigating anti-diabetic medication side effects
  • Improve skills for interpreting challenging echocardiograms
  • Examine strategies to optimize medical therapies at HF discharge
  • Discuss the pros and cons of ablation vs. medical therapy in HF patients with atrial arrhythmia
  • Explore the optimal management of acute stroke through cases that are relevant to cardiologists
  • Analyze the evidence and expert opinion on AF cardioversion
  • Examine the findings of COMMANDER, TRANSITION and other recent heart failure trials
  • Review guidelines and evidence on anticoagulation reversal agents
  • Discuss optimal management of atrial fibrillation in patients with heart failure
  • Understand the role of AF ablation for the prevention of stroke and mortality
  • Explore the role of cardiologists in the contemporary management of diabetes
  • Analyze the evidence and expert opinion on the optimal management of PAD
  • Discuss strategies for the management of acute AF in the emergency department
  • Examine strategies for the management of high-risk and vulnerable AF patients
  • Explore challenging cases in the management of syncope
  • Understand the evolving role of anticoagulant therapy in patients with CAD and AF post-PCI
  • Identify recent advances in the relationship between inflammation and CAD
  • Discuss practical aspects of NOAC dosing in patients who experience bleeding events

Subscribe to get the latest updates

Receive the latest news on the Arrhythmia Update Conference directly in your mailbox.